Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Lung Neoplasms

cabergoline has been researched along with Lung Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borson-Chazot, F; Ilie, MD; Raverot, G; Raverot, V; Tronc, F; Vasiljevic, A1
Colao, A; De Martino, MC; Faggiano, A; Franco, R; Kaltsas, GA; Marino, FZ; Napolitano, M; Negri, M; Patalano, R; Pivonello, C; Pivonello, R; Rocco, G; Rousaki, P; Sarnataro, M; Sciammarella, C1
Colao, A; Ferone, D; Lamberts, SW; Pivonello, R1
Albertelli, M; Arvigo, M; Barreca, A; Culler, MD; Ferone, D; Jaquet, P; Minuto, F; Moreau, JP; Saveanu, A; Semino, C; Taylor, JE1
Bodei, L; Colao, A; de Herder, WW; de Krijger, RR; Faggiano, A; Ferone, D; Hofland, LJ; Lamberts, SW; Lombardi, G; Pivonello, R1

Other Studies

5 other study(ies) available for cabergoline and Lung Neoplasms

ArticleYear
Cabergoline in severe ectopic or occult Cushing's syndrome.
    European journal of endocrinology, 2019, Jul-01, Volume: 181, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Intraductal Neoplasms; Rectal Neoplasms; Steroid Synthesis Inhibitors; Thymus Neoplasms; Treatment Outcome

2019
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
    Endocrine, 2017, Volume: 56, Issue:3

    Topics: Antineoplastic Agents; Cabergoline; Carcinoid Tumor; Cell Line, Tumor; Cell Survival; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Everolimus; Humans; Lung Neoplasms; Octreotide; Receptors, Dopamine D2; Receptors, Somatostatin; Signal Transduction; Somatostatin; TOR Serine-Threonine Kinases

2017
Cabergoline plus lanreotide for ectopic Cushing's syndrome.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: ACTH Syndrome, Ectopic; Adult; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Drug Therapy, Combination; Ergolines; Humans; Lung Neoplasms; Male; Peptides, Cyclic; Somatostatin

2005
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
    American journal of physiology. Endocrinology and metabolism, 2005, Volume: 289, Issue:6

    Topics: Acromegaly; Cabergoline; Cell Division; Cell Line, Tumor; Dopamine; Ergolines; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor II; Lung Neoplasms; Peptides, Cyclic; Pituitary Neoplasms; Receptors, Dopamine; Receptors, Somatostatin; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin

2005
Dopamine receptor expression and function in corticotroph ectopic tumors.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; Thymus Neoplasms

2007